Inicia sesión Registrate Mi Biblioteca idioma

Idioma

biblioteca idioma abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará la selección de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por International Parkinson & Movement Disorder Society.

Corea y enfermedad de Huntington

440 ARTíCULOS , VIENDO DEL 421 AL 435

PUBMED

PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model.

Giralt A, Saavedra A, Carretón O, Arumí H, Tyebji S, Alberch J, Pérez-Navarro E.

Hippocampus. 2013 Aug;23(8):684-95. doi: 10.1002/hipo.22128.

0

0

0

PUBMED

[The marginal with Huntington's disease].

Berg T.

Tidsskr Nor Laegeforen. 2013 Oct 29;133(20):2167. doi: 10.4045/tidsskr.13.0878. Norwegian. No abstract available.

0

0

0

PUBMED

Brain region- and age-dependent dysregulation of p62 and NBR1 in a mouse model of Huntington's disease.

Rué L, López-Soop G, Gelpi E, Martínez-Vicente M, Alberch J, Pérez-Navarro E.

Neurobiol Dis. 2013 Apr;52:219-28. doi: 10.1016/j.nbd.2012.12.008.

0

0

0

PUBMED

Heat shock response activation exacerbates inclusion body formation in a cellular model of Huntington disease.

Bersuker K, Hipp MS, Calamini B, Morimoto RI, Kopito RR.

J Biol Chem. 2013 Aug 16;288(33):23633-8. doi: 10.1074/jbc.C113.481945.

0

0

0

PUBMED

Management and outcome of pallidal deep brain stimulation in severe Huntington's disease.

Huys D, Bartsch C, Poppe P, Lenartz D, Huff W, Prütting J, Timmermann L, Klosterkötter J, Maarouf M, Rommel T, Hartmann A, Sturm V, Kuhn J.

Fortschr Neurol Psychiatr. 2013 Apr;81(4):202-5. doi: 10.1055/s-0033-1335097.

0

0

0

PUBMED

The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling.

Moreira Sousa C, McGuire JR, Thion MS, Gentien D, de la Grange P, Tezenas du Montcel S, Vincent-Salomon A, Durr A, Humbert S.

EMBO Mol Med. 2013 Feb;5(2):309-25. doi: 10.1002/emmm.201201546.

0

0

0

PUBMED

SPECT study of the nigrostriatal dopaminergic system in Huntington's disease.

Hwang WJ, Yao WJ.

J Neuroimaging. 2013 Apr;23(2):192-6. doi: 10.1111/j.1552-6569.2011.00671.x.

0

0

0

PUBMED

A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.

Hölter SM, Stromberg M, Kovalenko M, Garrett L, Glasl L, Lopez E, Guide J, Götz A, Hans W, Becker L, Rathkolb B, Rozman J, Schrewed A, Klingenspor M, Klopstock T, Schulz H, Wolf E, Wursta W, Gillis T,

PLoS One. 2013 Nov 22;8(11):e80923. doi: 10.1371/journal.pone.0080923.

0

0

0

PUBMED

Dendritic spine instability leads to progressive neocortical spine loss in a mouse model of Huntington's disease.

Murmu RP, Li W, Holtmaat A, Li JY.

J Neurosci. 2013 Aug 7;33(32):12997-3009. doi: 10.1523/JNEUROSCI.5284-12.2013.

0

0

0

PUBMED

[Chorea due to TITF1/NKX2-1 mutation: phenotypical description and therapeutic response in a family].

Salvado M, Boronat-Guerrero S, Hernández-Vara J, Álvarez-Sabin J.

Rev Neurol. 2013 May 16;56(10):515-20. Review. Spanish.

0

0

0

PUBMED

Ethical issues and Huntington's disease.

Kromberg JG, Wessels TM.

S Afr Med J. 2013 Oct 11;103(12 Suppl 1):1023-6. doi: 10.7196/samj.7146.

0

0

0

PUBMED

Hepatic mitochondrial dysfunction in manifest and premanifest Huntington disease.

Stüwe SH, Goetze O, Lukas C, Klotz P, Hoffmann R, Banasch M, Orth M, Schmidt WE, Gold R, Saft C.

Neurology. 2013 Feb 19;80(8):743-6. doi: 10.1212/WNL.0b013e318282514e.

0

0

0

PUBMED

De novo Huntington disease caused by 26-44 CAG repeat expansion on a low-risk haplotype.

Houge G, Bruland O, Bjørnevoll I, Hayden MR, Semaka A.

Neurology. 2013 Sep 17;81(12):1099-100. doi: 10.1212/WNL.0b013e3182a4a4af. No abstract available.

0

0

0

PUBMED

Huntington's disease: the road to progress.

Walker FO.

Lancet Neurol. 2013 Jul;12(7):624-5. doi: 10.1016/S1474-4422(13)70105-4. No abstract available.

0

0

0

PUBMED

Changes in brainstem serotonergic and dopaminergic cell populations in experimental and clinical Huntington's disease.

Jahanshahi A, Vlamings R, van Roon-Mom WM, Faull RL, Waldvogel HJ, Janssen ML, Yakkioui Y, Zeef DH, Kocabicak E, Steinbusch HW, Temel Y.

Neuroscience. 2013 May 15;238:71-81. doi: 10.1016/j.neuroscience.2013.01.071.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo HONcode Logo WIS

En colaboración con:

Zambon Neuroacademy